Grace Yang, a research technician at the MU Bond Life Sciences Center, and Kamlendra Singh, assistant director of the MU Molecular Interactions Core and Bond Life Sciences Center investigator, are trying to purify the COVID-19 omicron variant protein in order to find a better drug to fight the virus. DON SHRUBSHELL/COLUMBIA DAILY TRIBUNE
Roger McKinney Columbia Daily Tribune | USA TODAY NETWORK The omicron variant of COVID-19 has evolved mutations that allow it to evade many antibodies humans…
